EFEMP1 and glioblastoma: proposed that miR-338-5p suppresses GBM proliferation and metastasis by inhibiting EFEMP1, and miR-338-5p reportedly sensitizes GBM cells to radiotherapy by regulating genes involved in the DNA lesion response (57).